Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
Moderna (Nasdaq: MRNA) will present at Piper Sandler's 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 11:00 AM ET. A live webcast of the presentation will be available under Events and Presentations in the Investors section at investors.modernatx.com. A replay will be archived on Moderna's website for at least 30 days following the presentation.
Moderna (Nasdaq: MRNA) interverrà a Piper Sandler's 37th Annual Healthcare Conference il martedì 2 dicembre 2025 alle ore 11:00 ET. Una diretta webcast della presentazione sarà disponibile nella sezione Eventi e Presentazioni degli Investitori su investors.modernatx.com. Una replica sarà archiviata sul sito di Moderna per almeno 30 giorni dopo la presentazione.
Moderna (Nasdaq: MRNA) se presentará en Piper Sandler's 37th Annual Healthcare Conference el martes 2 de diciembre de 2025 a las 11:00 AM ET. Una transmisión en vivo de la presentación estará disponible en la sección Eventos y Presentaciones en la página de Inversores de investors.modernatx.com. Una repetición quedará archivada en el sitio web de Moderna durante al menos 30 días después de la presentación.
Moderna (Nasdaq: MRNA)는 Piper Sandler의 제37회 연례 헬스케어 컨퍼런스에서 2025년 12월 2일 화요일 오전 11:00 ET에 발표할 예정입니다. 발표의 생중계는 investors.modernatx.com의 투자자 섹션에 있는 이벤트 및 발표에서 확인할 수 있습니다. 발표 후 재방송은 적어도 30일간 Moderna의 웹사이트에 보관됩니다.
Moderna (Nasdaq : MRNA) sera présente à la 37e conférence annuelle sur les soins de santé de Piper Sandler le mardi 2 décembre 2025 à 11h00 ET. Une diffusion en direct de la présentation sera disponible dans la section Événements et Présentations dans la rubrique Investisseurs sur investors.modernatx.com. Une rediffusion sera archivée sur le site de Moderna pendant au moins 30 jours après la présentation.
Moderna (Nasdaq: MRNA) wird sich auf der Piper Sandler's 37th Annual Healthcare Conference vorstellen am Dienstag, dem 2. Dezember 2025 um 11:00 Uhr ET. Eine Live-Webcast der Präsentation wird unter Events and Presentations im Bereich Investoren unter investors.modernatx.com verfügbar sein. Eine Wiedergabe wird auf der Moderna-Website für mindestens 30 Tage nach der Präsentation archiviert.
موديرنا (ناسداك: MRNA) ستقدم في مؤتمر الرعاية الصحية السنوي السابع والثلاثين لشركة بايبـر سايندلر يوم الثلاثاء، 2 ديسمبر 2025 الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة. سيكون هناك بث حي للمقدمة متاح في قسم Events and Presentations في صفحة المستثمرين على investors.modernatx.com. سيتم أرشفة الإعادة على موقع Moderna لمدة لا تقل عن 30 يوماً بعد العرض.
- None.
- None.
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Piper Sandler's 37th Annual Healthcare Conference, on Tuesday, December 2nd at 11:00am ET
A live webcast of each of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire